Viking Therapeutics
VKTX
#3883
Rank
C$4.78 B
Marketcap
C$37.56
Share price
-2.64%
Change (1 day)
-28.88%
Change (1 year)

EPS for Viking Therapeutics (VKTX)

EPS in 2026 (TTM): C-$7.56

According to Viking Therapeutics 's latest financial reports the company's current EPS (TTM) is C-$7.75. In 2025 the company made an earnings per share (EPS) of C-$4.56 a decrease over its 2024 EPS that were of C-$1.44.

EPS history for Viking Therapeutics from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$7.5665.73%
2025C-$4.56218%
2024C-$1.44
2022C-$1.3126.39%
2021C-$1.0333.33%
2020C-$0.77
2018C-$0.56-51.25%
2017C-$1.15-20%
2016C-$1.44-64.08%
2015C-$4.00

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Ultragenyx Pharmaceutical
RARE
C-$7.45-3.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
C-$0.29-96.30%๐Ÿ‡บ๐Ÿ‡ธ USA